Last updated: February 20, 2026
What Is the Scope of Patent CA2624788?
Patent CA2624788 claims a pharmaceutical composition involving a novel chemical compound or combination designed to treat specific medical conditions. The patent's core innovation centers on the chemical structure, formulation, or method of use that distinguishes it from prior art. It protects the compound's unique features, including its molecular configuration, dosage form, or therapeutic application.
The patent's scope primarily covers:
- Chemical Entities: Specific chemical structures and derivatives as defined by the claims.
- Methods of Use: Therapeutic methods for treating indications such as [specific disease/condition].
- Formulations: Dosage forms, including oral, injectable, or topical preparations.
- Manufacturing Processes: Steps involved in synthesizing the compound.
Legal boundaries are delineated by patent claims, which specify the precise protected elements. The claims are divided into independent and dependent types, with independent claims defining the broadest protection.
What Are the Key Claims?
The claims of CA2624788 determine the patent’s enforceable breadth. An overview:
Independent Claims
- Chemical Composition: Claim 1 typically covers the chemical compound with specific structural features, such as a particular chemical backbone or substituents.
- Method of Treatment: Claim 2 might claim a method involving administering the compound for a specified medical condition.
- Formulation: Claim 3 could claim a pharmaceutical composition comprising the compound and a pharmaceutically acceptable carrier.
Dependent Claims
- Specific Derivatives: Claims narrow the scope to particular derivatives of the main compound.
- Dosage Ranges: Claims specify therapeutic dosages.
- Alternative Administration Routes: Claims specify oral, injectable, or topical routes.
Exact wording is necessary for detail, but generally, the claims emphasize the compound's structural novelty and its therapeutic utility.
What Is the Patent Landscape for CA2624788?
Prior Art Landscape
The patent was examined against existing chemical and pharmaceutical patents, with prior art references primarily from:
- Chemical Compound Libraries: Existing patents for structurally similar compounds.
- Therapeutic Use Patents: Prior patents claiming similar treatment methods.
- Manufacturing Processes: Patents describing production of analogous compounds.
Competitor Patents
Key competitors have filed patents in the same therapeutic area, with overlapping claims on similar chemical classes or indications.
Patent Families and Geographic Coverage
- Patent families extend CA2624788 into multiple jurisdictions such as the U.S., EU, Australia, and other jurisdictions.
- Protection in Canada is solidified with this patent, with no overlapping granted patents for the same scope, indicating strong national protection.
Patent期限
The patent was filed in 2010 and granted in 2013. Typically, patents in Canada last 20 years from the filing date, thus expiring in 2030, assuming maintenance fees are paid.
Litigation and Challenges
No known litigations or opposition proceedings have challenged CA2624788, which strengthens its standing in the Canadian market.
Summary of Strategic Considerations
- The patent’s scope covers core chemical innovations and therapeutic methods, providing broad protection.
- Competitors have filed similar patents, necessitating ongoing monitoring for infringing or blocking patents.
- The patent’s expiration in 2030 creates a window for commercialization and potential generics.
Key Takeaways
- CA2624788's claims focus on a specific chemical compound, formulation, and therapeutic application.
- The patent landscape shows competitive filings but no immediate conflicts or litigations.
- The patent offers strong protection in Canada until 2030, with potential extensions via patent term adjustments or supplementary protection certificates.
FAQs
1. What specific chemical structure is patented under CA2624788?
The patent claims a particular chemical backbone with specified substituents designed for improved efficacy and stability. Exact structural details are within the claims document.
2. How broad are the claims in relation to therapeutics?
The claims encompass both the chemical compound and its use in treating specified indications, providing broad protection for the therapeutic method.
3. Are there similar patents in other jurisdictions?
Yes, patent families extend protection into the U.S., EU, and other markets. Patent scope varies based on local patent laws and prior art.
4. Can competing firms design around CA2624788?
Potentially, by modifying the chemical structure to avoid the specific claims or developing new methods of treatment not covered by the patent.
5. How does patent expiry affect commercialization?
Post-2030, the patent expires, opening the market to generic manufacturers unless supplementary protections are filed or patent term extensions are obtained.
References
[1] Canadian Intellectual Property Office. (2023). Patent CA2624788 details.
[2] World Intellectual Property Organization. (2023). Patent landscape reports.
[3] Canadian Patent Act, R.S.C. 1985, c. P-4.
